A drug with the SMILES CCCCn1c(N)c(N(CCOC)C(=O)CSc2nnc(C)n2-c2ccc(OC)cc2)c(=O)[nH]c1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 22.067%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCCCn1c(N)c(N(CCOC)C(=O)CSc2nnc(C)n2-c2ccc(OC)cc2)c(=O)[nH]c1=O
CCCCn1c(N)c(N(CCOC)C(=O)CSc2nnc(C)n2-c2ccc(OC)cc2)c(=O)[nH]c1=O
N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-(2-methoxyethyl)-2-[[4-(4-methoxyphenyl)-5-methyl-1,2,4-triazol-3-yl]sulfanyl]acetamide